Clinical Scorecard: Utilizing Artificial Intelligence to Estimate Age from Echocardiographic Data as an Indicator of Cardiovascular Health

At a Glance

Key Highlights

• Deep learning ensemble model predicts age from echocardiographic videos with mean absolute error ~6.76 years and R² ~0.73.
• Predicted biological age correlates with increased risk of coronary artery disease, heart failure, stroke, and mortality.
• Model highlights cardiac structures (mitral valve, mitral apparatus, basal inferior wall) as key features for age prediction.

Guideline-Based Recommendations

Diagnosis

• Use multi-view echocardiographic data (PLAX, A2C, A4C, SC) for comprehensive cardiac assessment.
• Apply AI models to estimate biological age as a complementary tool to chronological age for cardiovascular risk stratification.

Management

• Consider biological age predictions to identify patients with accelerated cardiovascular aging for targeted interventions.
• Integrate echocardiographic age predictions with clinical biomarkers (creatinine, hemoglobin, BNP) to improve risk assessment.

Monitoring & Follow-up

• Monitor changes in predicted biological age over time to assess progression or improvement in cardiovascular health.
• Use survival analysis stratified by predicted age groups to guide prognosis and follow-up intensity.

Risks

• Be aware of potential variability in model performance across different populations and imaging centers.
• Recognize that AI predictions complement but do not replace clinical judgment and standard diagnostic criteria.

Patient & Prescribing Data

Patients undergoing echocardiographic evaluation without prior cardiac surgery to reduce bias.

Biological age prediction can identify patients at higher risk for cardiovascular events, guiding preventive and therapeutic strategies.

Clinical Best Practices

• Exclude patients with prior cardiac surgery when training or applying AI models to reduce bias.
• Use ensemble modeling combining multiple echocardiographic views to improve prediction accuracy.
• Validate AI models across diverse external cohorts to ensure generalizability.
• Incorporate explainability techniques (e.g., guided backpropagation) to understand model focus areas and enhance clinical trust.

References

• Kaplan-Meier survival analysis
• ResNet architecture
• Histogram Gradient Boosting